Supernus Pharmaceuticals Plans Q3 2025 Financial Results Call

Author: Henry Turner Updated: 10-21-2025 05:21 PM

Supernus Pharmaceuticals to Report Third Quarter Financial Results

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is set to announce its financial results for the third quarter of 2025. The company focuses on creating and commercializing innovative products for central nervous system (CNS) diseases, and the update will be shared after market hours on November 4, 2025.

Conference Call Details

Leading the discussion will be Jack Khattar, the President and CEO, alongside Tim Dec, the Senior Vice President and CFO. They will host a conference call to delve into the financial outcomes and business strategies of the third quarter on the same day at 4:30 p.m. ET. After the prepared remarks, the line will open for questions.

How to Access the Conference Call

Interested participants can pre-register for the call before the scheduled time. Following registration, a unique dial-in number and conference code will be provided, and it is recommended to join the call 15 minutes in advance to ensure connectivity.

Post-Call Replay

In case you miss the live session, a replay of the conference call will be available on Supernus Pharmaceuticals’ Investor Relations website. This recording will be accessible for a period of 60 days following the event.

About Supernus Pharmaceuticals, Inc.

Founded with a vision to improve lives, Supernus Pharmaceuticals specializes in CNS disorders, showcasing a rich portfolio that includes treatments for ADHD, Parkinson's disease, postpartum depression, epilepsy, and more. Their dedication to pioneering medicines in the realm of neuroscience reflects their commitment to address diverse healthcare needs.

Research and Product Pipeline

Supernus continues to invest in research and development to expand its array of product candidates targeting various CNS disorders. Their clinical trials are aimed at bringing forth innovative solutions for patients who suffer from these debilitating conditions, underscoring the company's role in advancing neuroscience.

Investor Relations

Supernus Pharmaceuticals maintains open channels for investor communication. For more information about upcoming announcements, results, and updates, investors are encouraged to visit their dedicated website.

Frequently Asked Questions

1. When will Supernus Pharmaceuticals announce their quarterly results?

The results will be announced after the market closes on November 4, 2025.

2. How can I join the conference call?

You can pre-register for the call to receive a dial-in number and conference code.

3. Will there be a replay of the call?

Yes, a replay will be available for 60 days on their Investor Relations website.

4. What is Supernus Pharmaceuticals focusing on?

The company is dedicated to developing treatments for CNS diseases, including ADHD and Parkinson's disease.

5. Who will lead the financial results conference call?

Jack Khattar and Tim Dec will lead the call to discuss the results and answer questions from participants.

About The Author

Hi there, As a writer and financial specialist, Henry Turner is passionate about guiding people through the complex world of finance. Having worked in finance for many years, I am an expert at simplifying difficult financial ideas into understandable, useful insights for my blog and articles. My goal is to arm you with the confidence and information you need to make wise financial choices.

Writing for a number of financial blogs has allowed me to interact with readers from novice investors looking for fresh ideas to seasoned investors starting their financial journeys. My mission is to enable everyone to understand and access finance, so enabling you to confidently and clearly reach your financial goals. I appreciate you traveling with me toward success and financial literacy.

Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.